CSat Investment Advisory’s MetLife MET Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q1
$2.33M Sell
38,267
-2,615
-6% -$144K 1.95% 12
2020
Q4
$1.92M Buy
40,882
+37,925
+1,283% +$1.64M 1.78% 16
2020
Q3
$110K Buy
2,957
+273
+10% +$10.4K 0.01% 420
2020
Q2
$98K Buy
2,684
+1,391
+108% +$48.4K 0.01% 479
2020
Q1
$40K Buy
1,293
+130
+11% +$5.76K 0.01% 579
2019
Q4
$59K Sell
1,163
-26,929
-96% -$1.3M 0.02% 573
2019
Q3
$1.32M Sell
28,092
-1,778
-6% -$84.8K 0.42% 44
2019
Q2
$1.48M Buy
29,870
+4,205
+16% +$198K 0.52% 33
2019
Q1
$1.09M Buy
25,665
+475
+2% +$21K 0.55% 44
2018
Q4
$1.03M Buy
25,190
+25,090
+25,090% +$1.08M 0.62% 37
2018
Q3
$5K Sell
100
-3,771
-97% -$172K ﹤0.01% 467
2018
Q2
$168K Buy
+3,871
New +$180K 0.09% 120

Other funds holding MET

CSat Investment Advisory's MET Position: Q1 2021 in Review

CSat Investment Advisory reduced its MetLife (MET) stake by 6.4% in Q1 2021, selling an estimated $144K and leaving 38,267 shares worth $2.33M. The position accounts for 1.95% of the portfolio, ranked #12.

CSat Investment Advisory first reported a position in MET in Q2 2018 and has held it in 12 quarters since. 1,080 funds tracked by Wall St. Rank hold MET as of Q1 2021.

  • CSat Investment Advisory held 38,267 shares of MetLife worth $2.33M as of Q1 2021.
  • CSat Investment Advisory sold 2,615 MetLife shares in Q1 2021, an estimated $144K.
  • MetLife made up 1.95% of CSat Investment Advisory's portfolio in Q1 2021, its #12 holding.
  • CSat Investment Advisory first reported a position in MetLife in Q2 2018 and has held it in 12 quarters since.
  • 1,080 funds tracked by Wall St. Rank held MetLife as of Q1 2021.

Based on CSat Investment Advisory's 13F filing for Q1 2021, filed 13 May 2021.